Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Malignant neoplasm of ovary
|
315 | 0.701 | 0.240 | 17 | 48728343 | missense variant | C/T | snv | 1.8E-03 | 1.6E-03 | 0.700 | 0 | |||||||
Malignant tumor of colon
|
688 | 0.701 | 0.240 | 17 | 48728343 | missense variant | C/T | snv | 1.8E-03 | 1.6E-03 | 0.700 | 0 | |||||||
Prostate Cancer, Hereditary, 9
|
1 | 0.701 | 0.240 | 17 | 48728343 | missense variant | C/T | snv | 1.8E-03 | 1.6E-03 | 0.700 | 0 | |||||||
PROSTATE CANCER, SUSCEPTIBILITY TO
|
6 | 0.701 | 0.240 | 17 | 48728343 | missense variant | C/T | snv | 1.8E-03 | 1.6E-03 | 0.700 | 0 | |||||||
Bladder Neoplasm
|
281 | 0.701 | 0.240 | 17 | 48728343 | missense variant | C/T | snv | 1.8E-03 | 1.6E-03 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Carcinoma of bladder
|
309 | 0.701 | 0.240 | 17 | 48728343 | missense variant | C/T | snv | 1.8E-03 | 1.6E-03 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Childhood Leukemia
|
140 | 0.701 | 0.240 | 17 | 48728343 | missense variant | C/T | snv | 1.8E-03 | 1.6E-03 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
leukemia
|
144 | 0.701 | 0.240 | 17 | 48728343 | missense variant | C/T | snv | 1.8E-03 | 1.6E-03 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Malignant neoplasm of urinary bladder
|
316 | 0.701 | 0.240 | 17 | 48728343 | missense variant | C/T | snv | 1.8E-03 | 1.6E-03 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Mammary Neoplasms
|
385 | 0.701 | 0.240 | 17 | 48728343 | missense variant | C/T | snv | 1.8E-03 | 1.6E-03 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Multiple malignancy
|
3 | 0.701 | 0.240 | 17 | 48728343 | missense variant | C/T | snv | 1.8E-03 | 1.6E-03 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Malignant neoplasm of breast
|
3417 | 0.701 | 0.240 | 17 | 48728343 | missense variant | C/T | snv | 1.8E-03 | 1.6E-03 | 0.720 | 0.500 | 2 | 2012 | 2016 | ||||
Breast Carcinoma
|
2793 | 0.701 | 0.240 | 17 | 48728343 | missense variant | C/T | snv | 1.8E-03 | 1.6E-03 | 0.020 | 0.500 | 2 | 2012 | 2016 | ||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.701 | 0.240 | 17 | 48728343 | missense variant | C/T | snv | 1.8E-03 | 1.6E-03 | 0.020 | 1.000 | 2 | 2013 | 2013 | ||||
Colorectal Carcinoma
|
1962 | 0.701 | 0.240 | 17 | 48728343 | missense variant | C/T | snv | 1.8E-03 | 1.6E-03 | 0.030 | 0.667 | 3 | 2013 | 2015 | ||||
Prostatic Neoplasms
|
31 | 0.701 | 0.240 | 17 | 48728343 | missense variant | C/T | snv | 1.8E-03 | 1.6E-03 | 0.030 | 1.000 | 3 | 2013 | 2017 | ||||
Hereditary Prostate Carcinoma
|
12 | 0.701 | 0.240 | 17 | 48728343 | missense variant | C/T | snv | 1.8E-03 | 1.6E-03 | 0.040 | 1.000 | 4 | 2012 | 2015 | ||||
Neoplasms
|
1644 | 0.701 | 0.240 | 17 | 48728343 | missense variant | C/T | snv | 1.8E-03 | 1.6E-03 | 0.040 | 1.000 | 4 | 2013 | 2017 | ||||
Primary malignant neoplasm
|
1374 | 0.701 | 0.240 | 17 | 48728343 | missense variant | C/T | snv | 1.8E-03 | 1.6E-03 | 0.040 | 0.750 | 4 | 2013 | 2015 | ||||
Malignant Neoplasms
|
1641 | 0.701 | 0.240 | 17 | 48728343 | missense variant | C/T | snv | 1.8E-03 | 1.6E-03 | 0.050 | 0.800 | 5 | 2013 | 2015 | ||||
Prostate cancer, familial
|
25 | 0.701 | 0.240 | 17 | 48728343 | missense variant | C/T | snv | 1.8E-03 | 1.6E-03 | 0.060 | 1.000 | 6 | 2012 | 2015 | ||||
Neoplastic Syndromes, Hereditary
|
6387 | 0.701 | 0.240 | 17 | 48728343 | missense variant | C/T | snv | 1.8E-03 | 1.6E-03 | 0.700 | 1.000 | 26 | 1996 | 2017 | ||||
Malignant neoplasm of prostate
|
1082 | 0.701 | 0.240 | 17 | 48728343 | missense variant | C/T | snv | 1.8E-03 | 1.6E-03 | 0.800 | 0.935 | 31 | 2012 | 2019 | ||||
Prostate carcinoma
|
1168 | 0.701 | 0.240 | 17 | 48728343 | missense variant | C/T | snv | 1.8E-03 | 1.6E-03 | 0.800 | 0.938 | 32 | 2012 | 2019 |